The Medserv group was unsuccessful in its bid to provide services offshore Cyprus.
Its Cypriot subsidiary renewed its lease at the Larnaca base for a further year to end of August 2017 and continues to provide shore base services to ENI – though at a very low level.
The subsidiary had responded to a tender from another IOC to provide shore base services in support of drilling operations offshore Cyprus, which were expected to resume in 2017.
JobsPlus offers specialised hands-on course for free
Following the launch of the new job-matching system available on www.jobsplus.gov.mt, JobsPlus will be offering a free two-hour course in collaboration with the Malta Communications Authority (MCA).
The scope of this hands-on course is to train jobseekers on how to use the new portal to successfully build their CV, outline their professional skills and competences, find jobs matching their profile, as well as provide them with the opportunity to gain expert tips and advice.
This course will be offered to persons who are interested in finding employment or would like to change their current job. Before attending the course, participants should ideally already have an active user account.
Interested applicants can register for the course by calling 2165 4940 or send an e-mail to training.jobsplus@gov.mt.
EC wins UK customer experience silver award
[attach id=536854 size="medium"][/attach]
Maltese-owned EC English Language Centres recently claimed another industry achievement, this time at the UK Customer Experience Awards 2016 in London.
EC was the only English language school to make the shortlist for this prestigious award and went on to win silver in its category, ‘Experience and Design Improvement’.
The international language school’s Orange Carpet Experience was presented alongside products from contenders such as Barclays, Sainsbury’s and Scottish Water.
Neurotech to list in Australia
Neurotech International Ltd, the parent company of AAT Research, will list on the Australian Securities Exchange after raising A$7m (€4.65m) in an initial public offering (IPO).
Neurotech is focused on the commercialisation of regulated medical solutions for the diagnosis and treatment of neurological disorders including autism spectrum disorder (ASD), epilepsy, anxiety and depression.
Neurotech’s first key product is Mente Autism, a clinical-quality EEG device that uses patented neurofeedback technology to help children with ASD. Mente Autism is the third iteration of the Mente system.
Proceeds raised from the IPO will fund sales and marketing initiatives for Mente Autism, research and development, a US clinical trial and other working capital as required.
Neurotech International and AAT Research were founded by Malta’s Adrian Attard Trevisan.